<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0268390" disease_type="Disease or Syndrome" abbrv="">Muckle-Wells syndrome</z:e> (MWS) is a dominantly inherited autoinflammatory disease characterized by <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rashes</z:e>, <z:hpo ids='HP_0001945'>fever</z:hpo>, <z:hpo ids='HP_0002829'>arthralgia</z:hpo>, <z:hpo ids='HP_0000407'>sensorineural deafness</z:hpo>, and the possible development of systemic AA <z:hpo ids='HP_0011034'>amyloidosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We used anakinra to treat a 22-year-old patient with MWS who had <z:hpo ids='HP_0000365'>deafness</z:hpo> and a high serum level of C-reactive protein (CRP) </plain></SENT>
<SENT sid="2" pm="."><plain>Following treatment with anakinra, the patient's CRP level normalized, and she recovered from <z:hpo ids='HP_0000365'>deafness</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The fact that this occurrence has never been previously reported strengthens the role of anakinra in MWS but also raises new questions about the physiopathology of such <z:hpo ids='HP_0000365'>deafness</z:hpo> </plain></SENT>
</text></document>